Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline AEHR Q1 2026 Earnings Narrowerthanexpected loss drives positive stock reaction UroGen Pharma Ltd URGN Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Upstream Bio Inc UPB Q1 2026 Earnings Narrower Than Expected Loss Reflects Operational Discipline LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited